index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Dynamin 2 Molecular docking Mitochondrial fission Inbred mdx Clinical trials Male Myogenesis Gene expression CaV subunits DMO Hepatocellular carcinoma LKB1 Humans Dystrophin-EGFP Dystrophie Musculaire de Becker BMD Cell Line Multi exon skipping Calcium Channels Multi resolution modeling Long noncoding RNA Cultured Liver Invivo BMD MES Dystrophin Myotendinous junction Muscular dystrophy Cell Biology Human Umbilical Vein Endothelial Cells CaVβs Centronuclear myopathy Inhibitors Base Sequence Delivery Duchenne muscular dystrophy CTNNB1 Calcium Hear DMD Duchenne muscular dystrophy DMD Immunoglobulin Fc Fragments/pharmacology Gene modifiers Duchenne DMD dystrophy Metabolism Ex-vivo Génomique Homeostasis Genomic Animal/physiopathology Dystrophie Musculaire de Duchenne DMD Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Knockout Long QT LncARN Muscles/physiopathology Muscle development Modificateurs de gènes Allele‐specific silencing therapy Dystrophin central domain Morphogenesis Becker muscular dystrophy BMD Cardiomyopathy Autophagy Dystrophine Dystrophie musculaire de Becker Muscle Activin Receptors Cachexia Muscle Biology Animals Energy Metabolism/drug effects Skeletal muscle Cells Exon skipping Mice Gene Expression Regulation/drug effects Multiresolution modeling Muscle Strength Cell homeostasis L-Type LncRNA Molecular Sequence Data Becker BMD muscular dystrophy Antisense oligonucleotides Muscular Atrophy Dystrophy Mdx mouse Epigenetics DHPR α1S NAD+ Inbred C57BL NNOS Becker muscular dystrophy Muscular Dystrophy MiARN CD38 Diseases Drp1 Cardiomyopathie